citalopram has been researched along with oxytocin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahlenius, S; Bjökstrand, E; Hillegaart, V; Uvnäs-Moberg, K | 1 |
| Harbuz, MS; Hesketh, S; Hogg, S; Jessop, DS | 1 |
| Ansseau, M; Geenen, V; Legros, JJ; Scantamburlo, G | 1 |
| Ansseau, M; Geenen, V; Hansenne, M; Legros, JJ; Scantamburlo, G | 1 |
| Batinić, B; Gurwitz, D; Israel-Elgali, I; Jukić, M; Oved, K; Pešić, V; Puškaš, N; Shomron, N; Stanić, D | 1 |
| Abd El-Rahman, SS; Abdelwahab, LA; El-Brairy, AI; El-Khatib, AS; Galal, OO; Khattab, MM | 1 |
1 review(s) available for citalopram and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for citalopram and oxytocin
| Article | Year |
|---|---|
Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial.
Topics: Administration, Intranasal; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxytocin; Psychiatric Status Rating Scales; Treatment Outcome | 2015 |
6 other study(ies) available for citalopram and oxytocin
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Oxytocin as a possible mediator of SSRI-induced antidepressant effects.
Topics: Animals; Antidepressive Agents; Cholecystokinin; Citalopram; Gastrins; Insulin; Male; Oxytocin; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Somatostatin; Zimeldine | 1999 |
Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Citalopram; Corticosterone; Corticotropin-Releasing Hormone; Drug Implants; In Situ Hybridization; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2005 |
Intranasal oxytocin as an adjunct to escitalopram in major depression.
Topics: Administration, Intranasal; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Oxytocin; Treatment Outcome | 2011 |
Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy.
Topics: Animals; Antidepressive Agents; Anxiety; Cell Adhesion Molecules; Citalopram; Corticosterone; Depression; Disease Models, Animal; Drug Synergism; Integrin beta3; Interneurons; Male; Neurogenesis; Oxytocin; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2021 |
Targeting the Oxytocin System to Ameliorate Early Life Depressive-Like Behaviors in Maternally-Separated Rats.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Brain; Citalopram; Depression; Enzyme-Linked Immunosorbent Assay; Female; Male; Maternal Deprivation; Open Field Test; Oxytocin; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Oxytocin | 2021 |